2B77:XETRA:XETRA-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 7.768

Change

+0.07 (+0.88)%

Market Cap

USD 0.50B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
2B77:XETRA
Relative Returns (From:    To: 2025-01-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.37 (+0.79%)

USD 102.61B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.21 (+0.19%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.06 (+0.22%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.05 (-0.34%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.03 (+0.52%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.04 (-0.16%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.05 (+0.33%)

USD 23.61B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.21 (-0.38%)

USD 18.97B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.05 (-0.46%)

USD 14.51B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.01 (+0.01%)

USD 12.26B

ETFs Containing 2B77:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.50% 89% A- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.50% 89% A- 84% B
Trailing 12 Months  
Capital Gain 22.93% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.93% 73% C 73% C
Trailing 5 Years  
Capital Gain 40.62% 61% D- 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.62% 57% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.70% 59% D- 59% D-
Dividend Return 8.70% 57% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.76% 32% F 44% F
Risk Adjusted Return 55.25% 47% F 53% F
Market Capitalization 0.50B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.